Inhibition of insulin, glucose-dependant insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity

被引:11
|
作者
Ranganath, LR [1 ]
Beety, JM
Morgan, LM
机构
[1] Epsom Gen Hosp, Dept Chem Pathol, Epsom KT18 7EG, Surrey, England
[2] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
obesity; insulin; GIP; GLP-1; octreotide; heparin; plasma lipoprotein lipase activity;
D O I
10.1055/s-2007-978729
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examines the immediate effect of modulating postprandial insulin and insulinotropic hormone (glucose-dependent insulinotropic polypeptide, GIP; glucagon-like peptide-1, GLP-1) secretion on the activation of lipoprotein lipase (LPL) in six lean and six obese age-matched women. Subjects were given, on two separate occasions, 340 kcal of carbohydrate alone or combined with an IV infusion of octreotide, (100 mu g infusion from 30 min before the meal for 150 min). Post-heparin LPL activity (10,000 U) was measured on each occasion 120 minutes post-carbohydrate. Following oral carbohydrate postprandial plasma insulin levels were significantly higher in obese subjects than in lean (p<0.01), Glucose tolerance was slightly impaired in obese subjects. Insulin, GIP and GLP-1 secretion post-carbohydrate was markedly reduced by octreotide in lean and obese subjects. LPL activity was similar in the two groups after carbohydrate administration and was unaffected by octreotide. Inhibition of postprandial insulin, GIP and GLP-1 secretion acutely did not reduce post-heparin LPL activity either in lean or obese subjects.
引用
收藏
页码:262 / 266
页数:5
相关论文
共 50 条
  • [21] The Circadian Rhythm in Glucagon-Like Peptide-1 (GLP-1) Secretion Is Entrained by Feeding and Regulates Insulin Secretion
    Gil-Lozano, Manuel
    Mingomataj, Erli
    Wu, Wei Kelly
    Brubaker, Patricia
    DIABETES, 2013, 62 : A512 - A512
  • [22] Carbohydrate-induced secretion of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
    Seino, Yusuke
    Maekawa, Ryuya
    Ogata, Hidetada
    Hayashi, Yoshitaka
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 : 27 - 32
  • [23] Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 secretion in humans: Characteristics and regulation
    Alsalim, Wathik
    Lindgren, Ola
    Ahren, Bo
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 354 - 361
  • [24] Effects of diet on Glucagon-Like Peptide-1 (GLP-1), Glucose and Insulin response of young horses
    Duarte, SRR
    Carlson, O
    Egan, J
    Ralston, S
    PFERDEHEILKUNDE, 2005, 21 : 117 - 119
  • [25] Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), positively impacts the altered microbiota of obese, diabetic, ovariectomized mice
    Silva-Veiga, Flavia Maria
    Marinho, Thatiany Souza
    de Souza-Mello, Vanessa
    Aguila, Marcia Barbosa
    Mandarim-de-Lacerda, Carlos Alberto
    LIFE SCIENCES, 2025, 361
  • [26] N-terminally truncated metabolite of glucose-dependent insulinotropic polypeptide (GIP) but not glucagon-like peptide-1 (GLP-1) improves glucose homeostasis in ob/ob mice through alleviation of insulin resistance
    Irwin, N.
    Parker, J. C.
    Gault, V. A.
    Greer, B.
    Harriott, P.
    O'Harte, F. P. M.
    Flatt, P. R.
    DIABETIC MEDICINE, 2007, 24 : 22 - 22
  • [27] A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1 and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice
    Gault, Victor A.
    Bhat, Vikas K.
    Irwin, Nigel
    Flatt, Peter R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (49) : 35581 - 35591
  • [28] THE INSULINOTROPIC ACTIONS OF GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) AND GLUCAGON-LIKE PEPTIDE-1(7-37) IN NORMAL AND DIABETIC SUBJECTS
    ELAHI, D
    MCALOONDYKE, M
    FUKAGAWA, NK
    MENEILLY, GS
    SCLATER, AL
    MINAKER, KL
    HABENER, JF
    ANDERSEN, DK
    REGULATORY PEPTIDES, 1994, 51 (01) : 63 - 74
  • [29] Preserved Inhibitory Effect of Glucagon-Like Peptide-1 (GLP-1) on Glucagon Secretion in Type 2 Diabetes Mellitus
    Hare, Kristine J.
    Knop, Filip K.
    Asmar, Meena
    Larsen, Steen
    Madsbad, Sten
    Holst, Jens J.
    Vilsboll, Tina
    DIABETES, 2009, 58 : A372 - A372
  • [30] Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on β-cell secretion and insulin clearance in mice
    Pacini, Giovanni
    Thomaseth, Karl
    Ahren, Bo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2010, 59 (07): : 988 - 992